Remove Clinical Pharmacology Remove Communication Remove Pharmaceutical Companies
article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

Strengthening logistical capabilities One of the most unnecessary clinical trial burdens can be site inefficiencies, particularly where sites exist that do not recruit. Central to this is embracing the power of strategic collaborations , through partnering with other pharmaceutical companies and academia.

article thumbnail

FDA drug dosage optimisation guidelines signal clinical trial reform

Pharmaceutical Technology

However, Amgen and other pharmaceutical companies have been criticised when they opted to choose the drug’s dosage based on the MTD model, which is commonly used in dose-finding trials. Impact on the industry Veal says that for a lot of pharmaceutical companies there is no “big drive to think about optimizing treatment” post-licensing.

Dosage 115